The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History® seminar to Midland, for the first time, 11:30 a.m. to 1:30 p.m., Tuesday, April 12, at the Midland Country Club, 6101 N. Highway 349.
The American Society of Clinical Oncology (ASCO) will recognize two physician-scientists from The University of Texas MD Anderson Cancer Center with two of its highest distinctions at its annual meeting in Chicago.
According to the 2017 edition of the influential Best Graduate Schools guide, The University of Texas Health Science Center at Houston (UTHealth) School of Nursing has climbed to No. 23 among 519 master’s programs surveyed by U.S. News & World Report.
A team of investigators from Houston Methodist Research Institute may have transformed the treatment of metastatic triple negative breast cancer by creating the first drug to successfully eliminate lung metastases in mice. This landmark study appears today in Nature Biotechnology (early online edition).
A new study from The University of Texas MD Anderson Cancer Center evaluating the use of neurofeedback found a decrease in the experience of chronic pain and increase quality of life in patients with neuropathic pain.
Neurosurgeons at Houston Methodist Hospital report the successful treatment of deep-seated thalamic and brain stem cavernous angiomas in an upcoming article in the Journal of Neurosurgery (online March 8).
Harris Health System treats more than 350 patients annually through its Low Vision Clinic where patients suffering from congenital diseases like glaucoma or cataracts, diabetic retinopathy, macular degeneration, trauma or stroke get a chance to regain some vision independence. Patients are evaluated and paired up with high-powered lenses and work with an occupational therapist who trains them on the equipment or ways to maximize their vision levels. Now, patients also have access to a new support group where like-diagnosed patients can share and learn from each other.
The Michael & Susan Dell Center for Healthy Living at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health Austin Regional Campus hosted its 10th annual Michael & Susan Dell Lectureship in Child Health at 2 p.m. on Thursday at the Blanton Museum of Art.
Consuming a diet with a high glycemic index, a classification of how rapidly carbohydrates elevate blood sugar levels, was independently associated with an increased risk of developing lung cancer in non-Hispanic whites, according to a new epidemiologic study from The University of Texas MD Anderson Cancer Center.
Melissa Valerio, Ph.D., regional dean of The University of Texas Health Science Center at Houston (UTHealth) School of Public Health San Antonio Regional Campus, has been named a 2016 Chancellor’s Fellow for The University of Texas System Office of Health Affairs.
PGK1, a glycolytic enzyme, has been found to play a role in coordinating cellular processes crucial to cancer metabolism and brain tumor formation, according to results published in today’s online issue of Molecular Cell.
The University of Texas MD Anderson Cancer Center brings its Making Cancer History® seminar to Indian Wells, Calif. on Tuesday, March 8, at the Renaissance Indian Wells Resort & Spa, 44400 Indian Wells Lane.
A study that revealed new findings about prostate cells may point to future strategies for treating aggressive and therapy-resistant forms of prostate cancer.
When middle school youth listen to rap music for three or more hours each day, they are more likely to believe that their peers are having sex and subsequently more likely to initiate sex by ninth grade, according to a study by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Many patients showing signs of dementia are quickly diagnosed with Alzheimer’s disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
The Children’s Learning Institute, a part of The University of Texas Health Science Center at Houston (UTHealth), is inviting Texas Rising Star certified providers and former Texas School Ready participants to sign up for TSR Online, an online platform that includes free access to progress monitoring tools and professional development resources. Hundreds of Texas school districts, charter schools and Head Start programs currently have access to TSR Online tools and resources at no cost, directly impacting more than 100,000 young Texans this year alone.
A new, minimally invasive procedure to treat post-surgery patients suffering from chronic sinusitis is being offered by the UT Physicians Otorhinolaryngology – Head & Neck Surgery clinic, in conjunction with Memorial Hermann-Texas Medical Center. UT Physicians is the only academic medical practice in the country to offer this treatment in the office setting.
The University of Texas MD Anderson Cancer Center was awarded $14 million this week from the Cancer Prevention and Research Institute of Texas (CPRIT) for the recruitment of three cancer scientists.
Current staging system is inadequate; for the first time, research proves that staging based on nasopharyngeal “N” categories offers more predictive value
ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia (AML), according to a recent clinical study.
A new study will evaluate the use of whole umbilical cord blood to help the brain heal quicker after an ischemic stroke.
The University of Texas MD Anderson Cancer Center will share novel research findings, cancer prevention tips and advances driven by the institution’s Moon Shots Program at an educational event in Palm Beach, Feb. 20 at The Colony Hotel, 155 Hammon Ave.
The surgical intermediate care unit at Harris Health System’s Ben Taub Hospital now has the distinction of being one of two intermediate units in Houston, and one of three in Texas, to receive the Beacon Award (Silver Level) for Excellence in patient care by the American Association of Critical-Care Nurses. The Beacon award is a three-year recognition for the hospital. Of approximately 30,000 patient-care units in 5,700 hospitals in the United States, only 329 units are currently recognized and only 45 intermediate care units are designated nationwide.
Researchers at The University of Texas MD Anderson Cancer will share in a funding award of $13.4 million with hopes of answering one of the biggest questions in the current management of breast cancer: do women with the earliest form of the disease, ductal carcinoma in situ (DCIS), need invasive surgery?
Chemotherapy treatment is a necessary evil in the fight against most cancers and has prolonged life for millions of people. However, many cancer survivors suffer from an increased risk of heart problems related to the toxic effect some chemotherapy drugs have on the heart. The key is catching it early.
An international collaborative study has revealed detailed new information about diffuse glioma, the most common type of tumor found in some 80 percent of adult brain cancer patients, raising hopes that better understanding of these disease groups may aid improved clinical outcomes.
In response to low national vaccination rates for the human papillomavirus (HPV), The University of Texas MD Anderson Cancer Center has joined with the 68 other National Cancer Institute (NCI)-designated cancer centers in issuing a statement calling for increased HPV vaccination for the prevention of cancer.
Nearly 100 members of The University of Texas Health Science Center at Houston (UTHealth) community and visitors celebrated the opening of the UTHealth Veterans’ Bachelor of Science in Nursing (VBSN) program on Friday, Jan. 22. They welcomed the first three VBSN students, who were admitted to the new program this semester.
A new procedure developed by surgeons at The University of Texas MD Anderson Cancer Center improves the accuracy of axillary staging and pathologic evaluation in clinically node-positive breast cancer, and reduces the need for a more invasive procedure with debilitating complications.
Treatment of multiple sclerosis (MS) and other inflammatory diseases may benefit by new findings from a study that identified potential therapeutic targets for a devastating disease striking some 2.3 million people worldwide.
About 12,000 women in the United States are diagnosed with cervical cancer each year, a diagnosis that could be avoided by early detection and preventive vaccination. Dr. Lois Ramondetta, chief, Gynecologic Oncology, Harris Health System's Lyndon B. Johnson Hospital, and professor, University of Texas M.D. Anderson Cancer Center, urge women to get Pap tests and youngster-boys and girls-to get vaccinated against the human papillomavirus (HPV), a cause of cervical cancer. Cervical cancer patient Dora Chaisson joins the advocacy effort.
The immunotherapy platform at The University of Texas MD Anderson Cancer Center and the global biopharmaceutical company AbbVie will join forces to find new ways to unleash the immune system’s potential to fight cancer.
Findings from a new study reveal that PARP inhibitors, an emerging class of drugs being studied in cancer clinical trials, may be enhanced by combining them with inhibitors targeting an oncogene known as c-MET which is overexpressed in many cancers.
More than 120,000 people are currently on the kidney transplant waiting list, some waiting anywhere from four to six years. Some of those people will die before the new kidney comes. Asking a family member or friend to donate a kidney might be difficult, but it has many advantages without affecting the donor.
Sally Vernon, Ph.D., chair of the Department of Health Promotion and Behavioral Sciences at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, has been appointed to the Board of Scientific Counselors for Clinical Sciences and Epidemiology at the National Cancer Institute (NCI).
The University of Texas MD Anderson Cancer Center today announced that it has entered into a collaborative research and development agreement with Enumeral Biomedical Holdings Inc.
In cancer, cell signaling pathways are the critical chain of events that can either quash or quicken disease progression.
Harris Health System’s Ben Taub Hospital has earned the coveted international recognition of Baby-Friendly Hospital, joining a select number of such facilities in Houston and Texas. The designation means the hospital meets or exceeds rigorous guidelines that promote high levels of newborn breastfeeding and mother-baby bonding.
Kymab, a leading human monoclonal antibody biopharmaceutical company, and The University of Texas MD Anderson Oncology Research for Biologics and Immunotherapy Translation (ORBIT) unit today announced a strategic cancer drug discovery and development alliance.
The high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center.
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
Michelle Barton, Ph.D., one of two deans at The University of Texas Graduate School of Biomedical Sciences at Houston, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Fellowship is an honor bestowed to AAAS members by their peers.
Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson Cancer Center report online at the Annals of Oncology.
Feeling sad can alter levels of stress-related opioids in the brain and increase levels of inflammatory proteins in the blood that are linked to increased risk of comorbid diseases including heart disease, stroke and metabolic syndrome, according to a study by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Craig Jordan, Ph.D., a breast cancer research pioneer known for his development of the therapeutic drug tamoxifen, has been named a recipient of the Sir James Black Award from the British Pharmacological Society.
Patients with lymphoma or myeloma and their caregivers will have access to leading experts in this field of cancer during an upcoming symposium to be held Jan. 9 in Houston.
Postponing the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase risk of death for breast cancer patients, particularly those with triple-negative breast cancer (TNBC), according to a new study from The University of Texas MD Anderson Cancer Center.
Treatment modality is also the most expensive in younger patients, MD Anderson study finds
Researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, in collaboration with the National School of Tropical Medicine at Baylor College of Medicine, have identified a molecule expressed by Trypanosoma cruzi (T. cruzi) that may facilitate the parasite’s evasion of the host’s immune system.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right